• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Science . Senolytics reduce coronavirus-related mortality in old mice

tetano

Editor, Senior Moderator
Science


. 2021 Jun 8;eabe4832.
doi: 10.1126/science.abe4832. Online ahead of print.
Senolytics reduce coronavirus-related mortality in old mice


Christina D Camell[SUP] #[/SUP][SUP] 1 [/SUP], Matthew J Yousefzadeh[SUP] #[/SUP][SUP] 1 [/SUP], Yi Zhu[SUP] #[/SUP][SUP] 2 3 [/SUP], Larissa G P Langhi Prata[SUP] #[/SUP][SUP] 2 [/SUP], Matthew A Huggins[SUP] 4 [/SUP], Mark Pierson[SUP] 4 [/SUP], Lei Zhang[SUP] 1 [/SUP], Ryan D O'Kelly[SUP] 1 [/SUP], Tamar Pirtskhalava[SUP] 2 [/SUP], Pengcheng Xun[SUP] 5 [/SUP], Keisuke Ejima[SUP] 5 [/SUP], Ailing Xue[SUP] 2 [/SUP], Utkarsh Tripathi[SUP] 2 [/SUP], Jair Machado Espindola-Netto[SUP] 2 [/SUP], Nino Giorgadze[SUP] 2 [/SUP], Elizabeth J Atkinson[SUP] 2 6 [/SUP], Christina L Inman[SUP] 2 [/SUP], Kurt O Johnson[SUP] 2 [/SUP], Stephanie H Cholensky[SUP] 1 [/SUP], Timothy W Carlson[SUP] 5 [/SUP], Nathan K LeBrasseur[SUP] 2 3 [/SUP], Sundeep Khosla[SUP] 2 7 [/SUP], M Gerard O'Sullivan[SUP] 8 9 [/SUP], David B Allison[SUP] 5 [/SUP], Stephen C Jameson[SUP] 4 [/SUP], Alexander Meves[SUP] 10 [/SUP], Ming Li[SUP] 10 [/SUP], Y S Prakash[SUP] 3 11 [/SUP], Sergio E Chiarella[SUP] 12 [/SUP], Sara E Hamilton[SUP] 13 [/SUP], Tamara Tchkonia[SUP] 14 3 [/SUP], Laura J Niedernhofer[SUP] 15 [/SUP], James L Kirkland[SUP] 14 3 16 [/SUP], Paul D Robbins[SUP] 15 [/SUP]



Affiliations

Abstract

The COVID-19 pandemic has revealed the pronounced vulnerability of the elderly and chronically-ill to SARS-CoV-2-induced morbidity and mortality. Cellular senescence contributes to inflammation, multiple chronic diseases, and age-related dysfunction, but effects on responses to viral infection are unclear. Here, we demonstrate that senescent cells (SnC) become hyper-inflammatory in response to pathogen-associated molecular patterns (PAMPs), including SARS-CoV-2 Spike protein-1, increasing expression of viral entry proteins and reducing anti-viral gene expression in non-SnCs through a paracrine mechanism. Old mice acutely infected with pathogens that included a SARS-CoV-2-related mouse β-coronavirus experienced increased senescence and inflammation with nearly 100% mortality. Targeting SnCs using senolytic drugs before or after pathogen exposure significantly reduced mortality, cellular senescence, and inflammatory markers and increased anti-viral antibodies. Thus, reducing the SnC burden in diseased or aged individuals should enhance resilience and reduce mortality following viral infection, including SARS-CoV-2.
 
Back
Top Bottom